KDR and peripheral vascular disease: Further, impaired mobilization of CD34+KDR+ EPCs in diabetic subjects was shown [69], as was a reduction of CD133+/KDR+ EPCs [70] and CD34+KDR+ EPCs [69, 71] in T2D and its association with peripheral vascular disease risk [69].